» Human Prekallikrein congenital Deficient Plasma

RESEARCH DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (KITS)

Human Prekallikrein congenital Deficient Plasma

Fresh frozen plasmas

Native coagulation factor deficient plasmas are fresh frozen plasmas obtained exclusively from donors with severe congenital prekallikrein deficiency.

These native coagulation factor-deficient plasmas are recommended for the evaluation of the activity of coagulation factors by the method of assaying the level of prothrombin (PT) or activated partial thromboplastin time (TCA) requiring the use of a plasma lacking in factor (<1%) in hemostasis.

Reference	Presentation	Packaging
7-1700	Kit	5 x 1.0 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Prekallikrein is a glycoprotein, a serine protease zymogen. Non-covalently complexed with high molecular weight kininogen.
Prekallikrein participates in the activation of coagulation, fibrinolysis, the generation of kinins and inflammatory phenomena. It is activated into kallikrein by FXIIa.

- The frozen, native plasmas certified to have less than 1% for the deficient factor considered, both for the antigenic and functional assay in hemostasis.
- This plasma is stable, if stored at -40 to -80 °C, until the end of the month of the expiration date indicated on the package.

- None of these plasmas contain inhibitors.
- No additives or preservatives.
- Freezing the plasmas makes it possible to keep the matrix perfectly intact and to avoid reconstitution.
- Packaging in plastic cryotubes suitable for all STA-R type micro-cup supports.

- 5 cryotubes x 1 mL of frozen plasma

Human Factor IX congenital Deficient Plasma
Human Factor V congenital Deficient Plasma
Human Factor VII congenital Deficient Plasma
Human Factor VIII congenital Deficient Plasma
Human Factor VIII congenital Deficient Plasma with inhibitor
Human Factor X congenital Deficient Plasma
Human Factor XI congenital Deficient Plasma
Human Factor XII congenital Deficient Plasma
Human Factor XIII congenital Deficient Plasma

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer.
	Distributor.

RESEARCH DEFICIENT PLASMAS CONGENITAL DEFICIENT PLASMAS (KITS)

Human Prekallikrein congenital Deficient Plasma

Fresh frozen plasmas

Price list, safety data sheets and notices are accessible to our registered customers.

Cryopep Catalogue
Thrombosis Haemostasis 2023

Cryopep Catalogue
Haemostasis Research 2023

Cryopep DEFICIENT PLASMAS

Product sheet Human Prekallikrein congenital Deficient Plasma

You must identify yourself to search for a certificate of analysis

Human Prekallikrein congenital Deficient Plasma

Fresh frozen plasmas

Product sheet

Price list, safety data sheets and notices are accessible to our registered customers.